Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and Granulocytic Leukemia, Chronic

oxazoles has been researched along with Granulocytic Leukemia, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, ZP; Chai, XX; Fu, YJ; Xiong, YZ; Yang, MT; Zhou, Y1
Chen, C; Ding, K; Jin, B; Pan, J; Shi, X; Sun, X; Wu, Y; Yeung, SC1
Cressey, LI; Døskeland, SO; Gjertsen, BT; Gliemann, J; Hokland, P; Jensen, PH; Lanotte, M; Madsen, P; Mellgren, G; Vintermyr, OK1

Other Studies

3 other study(ies) available for oxazoles and Granulocytic Leukemia, Chronic

ArticleYear
2-Aminoxazole and 2-Aminothiazole Dasatinib Derivatives as Potent Inhibitors of Chronic Myeloid Leukemia K562 Cells.
    Archiv der Pharmazie, 2016, Volume: 349, Issue:7

    Topics: Cell Line, Tumor; Cell Proliferation; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxazoles; Structure-Activity Relationship; Thiazoles

2016
Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor α and bcr-abl oncogene addiction in malignant hematologic cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Apr-01, Volume: 18, Issue:7

    Topics: Animals; Apoptosis; Blotting, Western; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Female; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred BALB C; Mice, Nude; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Oxazoles; Phosphorylation; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thiazoles; Xenograft Model Antitumor Assays

2012
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis.
    British journal of cancer, 1994, Volume: 70, Issue:5

    Topics: Apoptosis; Biomarkers, Tumor; Bone Marrow; Cell Death; Ethers, Cyclic; Humans; Intracellular Fluid; Isomerism; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Marine Toxins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Plasminogen Activator Inhibitor 2; Tumor Cells, Cultured

1994